Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2P95-mutated neoplasms - Todisco, Gabriele; Creignou, Maria; Gallì, Anna; Guglielmelli, Paola; Rumi, Elisa; Roncador, Marco; Rizzo, Ettore; Nannya, Yasuhito; Pietra, Daniela; Elena, Chiara; Bono, Elisa; Molteni, Elisabetta; et al. (Leukemia, 2021)
Keywords: 45; 45/23; 631/67/1990/1673; 692/308/2056; Acute myeloid leukemia; Cancer Research; Critical Care Medicine; Genes; Genotype & phenotype; Genotypes; Hematology; Heterogeneity; Intensive; Internal Medicine; Janus kinase 2; Leukemia; Leukocytosis; Medicine; Medicine & Public Health; Monocytosis; Mutation; Myelodysplastic syndrome; Myelodysplastic syndromes; Myelofibrosis; Myeloid leukemia; Neoplasms; Oncology; Patients; Phenotypes; Regression analysis; Runx1 protein; Sideroblasts; Splicing factors; Tumors